BRCA1 and serous adenocarcinoma: A recent meta‐analysis showed that on average only 16.3% (430/2636) of all reported primary ovarian tumors are showing signs of BRCA1 promoter hypermethylation, but that hypermethylation is strongly correlated with high‐grade serous carcinomas [9].